NewAmsterdam Pharma Company N.V. Ordinary Shares Net Asset Quality Index
NewAmsterdam Pharma Company N.V. Ordinary Shares net asset quality index. NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Net Asset Quality Index of 92.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $786.43 Million minus total liabilities of $58.36 Million yields net assets of $728.07 Million. A higher index indicates a stronger, lower-leverage balance sheet. See NewAmsterdam Pharma Company N.V. Ordinar net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of NewAmsterdam Pharma Company N.V. Ordinary Shares (2020–2024)
Net asset quality index of NewAmsterdam Pharma Company N.V. Ordinary Shares from 2020 to 2024. This chart shows how NewAmsterdam Pharma Company N.V. Ordinary Shares's Net Asset Quality Index has evolved across 5 annual periods from 2020 to 2024. As of September 2025, the index stands at 92.6%, representing net assets of $728.07 Million against total assets of $786.43 Million USD. Check NAMS strategic asset allocation to assess the company's strategic physical and investment asset allocation.
NewAmsterdam Pharma Company N.V. Ordinary Shares Net Asset Quality Index by Year (2020–2024)
NewAmsterdam Pharma Company N.V. Ordinary Shares net asset quality index by year from 2020 to 2024. The table below presents the year-by-year Net Asset Quality Index for NewAmsterdam Pharma Company N.V. Ordinary Shares from 2020 to 2024, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of NewAmsterdam Pharma Company N.V. Ordinar.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 87.6% | $757.50 Million | $864.62 Million | $107.12 Million | ▲ +4.5 pp |
| 2023 | 83.1% | $288.39 Million | $347.10 Million | $58.70 Million | ▼ -6.8 pp |
| 2022 | 89.9% | $430.07 Million | $478.50 Million | $48.43 Million | ▲ +6.6 pp |
| 2021 | 83.3% | $56.63 Million | $67.99 Million | $11.36 Million | ▼ -7.8 pp |
| 2020 | 91.1% | $127.46 Million | $139.87 Million | $12.41 Million | — |